Quarterly report pursuant to Section 13 or 15(d)

6. STOCK OPTIONS AND WARRANTS

v3.20.2
6. STOCK OPTIONS AND WARRANTS
3 Months Ended
Jul. 31, 2020
Share-based Payment Arrangement [Abstract]  
STOCK OPTIONS AND WARRANTS

NOTE 6 – STOCK OPTIONS AND WARRANTS

 

Stock Options

 

As of July 31, 2020, the Company had 68,700,000 outstanding stock options to its directors and officers (collectively, “Employee Options”) and consultants (“Non-Employee Options”).

 

During the three months ended July 31, 2020 and 2019, the Company granted 1,500,000 and 1,500,000 Employee Options, respectively.

 

The fair value of the Employee Options at the date of grant was estimated using the Black-Scholes-Merton option-pricing model, based on the following weighted average assumptions:

 

    Three Months Ended July 31,  
    2020     2019  
Risk-free interest rate     0.3 %     2.1 %
Expected volatility     91 %     91 %
Expected term (years)     2.5       2.5  
Expected dividend yield     0.00 %     0.00 %

 

The Company’s computation of expected volatility is based on the historical daily volatility of its publicly traded stock. For stock option grants issued during the three months ended July 31, 2020 and 2019, the Company used a calculated volatility for each grant. The Company lacks adequate information about the exercise behavior now and has determined the expected term assumption under the simplified method provided for under ASC 718, which averages the contractual term of the Company’s stock options of five years with the average vesting term of two and one-half years for an average of three years. The dividend yield assumption of zero is based upon the fact the Company has never paid cash dividends and presently has no intention of paying cash dividends. The risk-free interest rate used for each grant is equal to the U.S. Treasury rates in effect at the time of the grant for instruments with a similar expected life.

 

During the three months ended July 31, 2020 and 2019, the Company granted no Non-Employee Options.

 

A summary of the Company’s stock option activity and related information for the three months ended July 31, 2020 is shown below:

 

    Options     Weighted
Average
Exercise Price
    Weighted
Average
Grant Date
Fair Value
per Share
 
                   
Outstanding, April 30, 2020     67,200,000     $ 0.06     $ 0.06  
Issued     1,500,000       0.02       0.02  
Forfeited                  
Exercised                  
Outstanding, July 31, 2020     68,700,000     $ 0.06     $ 0.06  
Exercisable, July 31, 2020     64,950,000     $ 0.06     $  
Vested and expected to vest     68,700,000     $ 0.06     $  

  

A summary of the activity for unvested stock options during the three months ended July 31, 2020 is as follows:

 

    Options     Weighted
Average
Grant Date
Fair Value
per Share
 
             
Unvested, April 30, 2020     6,200,000     $ 0.05  
Granted     1,500,000       0.02  
Vested     (3,950,000 )      
Forfeited            
Unvested, July 31, 2020     3,750,000     $ 0.03  

 

The Company recorded $72,317 and $116,914 of stock-based compensation related to the issuance of Employee Options to certain officers and directors in exchange for services during the three months ended July 31, 2020 and 2019, respectively. At July 31, 2020, there remained $88,526 of unrecognized compensation expense related to unvested Employee Options granted to officers and directors, to be recognized as expense over a weighted-average period of the remaining five months in the calendar year. The unvested options vest at 750,000 shares per month and are expected to be fully vested on December 31, 2020.

 

The Company recorded $0 and $9,411 of stock-based compensation related to the issuance of Non-Employee Options in exchange for services during the three months ended July 31, 2020 and 2019, respectively. There were no unvested Non-Employee Options on July 31, 2020.

 

The following table summarizes the outstanding stock options by exercise price at July 31, 2020:

 

Exercise Price     Number of
Options
Outstanding
    Weighted
Average
Remaining
Contractual Life
of Outstanding
Options (years)
    Weighted
Average
Exercisable
Price
    Number of
Options
Exercisable
    Weighted Average
Exercise Price
of Exercisable
Options
 
$ 0.063       15,600,000       0.25     $ 0.063       15,600,000     $ 0.063  
$ 0.104       10,450,000       1.03     $ 0.104       10,450,000     $ 0.104  
$ 0.0685       600,000       0.75     $ 0.0685       600,000     $ 0.0685  
$ 0.058       2,450,000       1.43     $ 0.058       2,450,000     $ 0.058  
$ 0.0734       1,200,000       0.96     $ 0.0734       1,200,000     $ 0.0734  
$ 0.0729       1,800,000       1.94     $ 0.0729       1,800,000     $ 0.0729  
$ 0.089       1,200,000       1.96     $ 0.089       1,200,000     $ 0.089  
$ 0.0553       500,000       1.10     $ 0.0553       500,000     $ 0.0553  
$ 0.0558       9,000,000       1.45     $ 0.0558       9,000,000     $ 0.0558  
$ 0.0534       1,200,000       3.10     $ 0.0534       1,200,000     $ 0.0534  
$ 0.0539       1,000,000       1.38     $ 0.0539       1,000,000     $ 0.0539  
$ 0.0683       500,000       1.46     $ 0.0683       500,000     $ 0.0683  
$ 0.0649       500,000       1.60     $ 0.0649       500,000     $ 0.0649  
$ 0.0495       9,000,000       1.88     $ 0.0495       9,000,000     $ 0.0495  
$ 0.0380       1,200,000       4.15     $ 0.0380       1,200,000     $ 0.0380  
$ 0.0404       1,000,000       1.88     $ 0.0404       1,000,000     $ 0.0404  
$ 0.0370       500,000       1.96     $ 0.0370       500,000     $ 0.0370  
$ 0.0340       500,000       2.10     $ 0.0340       500,000     $ 0.0340  
$ 0.0408       9,000,000       2.66     $ 0.0408       5,250,000     $ 0.0408  
$ 0.0240       1,000,000       2.38     $ 0.0240       1,000,000     $ 0.0240  
$ 0.0247       500,000       2.46     $ 0.0247       500,000     $ 0.0247  
  Total       68,700,000       1.47     $ 0.06       64,950,000     $ 0.06  

 

The aggregate intrinsic value of outstanding options as of July 31, 2020 was zero. This represents options whose exercise price was less than the closing fair market value of the Company’s common stock on July 31, 2020 of approximately $0.014 per share.

 

Warrants

 

The warrants issued by the Company are equity-classified. The fair value of the warrants was recorded as additional paid-in-capital, and no further adjustments are made.

 

For stock warrants paid in consideration of services rendered by non-employees, the Company recognizes consulting expense in accordance with the requirements of ASC 505.

 

Effective June 13, 2019, the Company issued a Common Stock Purchase Warrant to Aeon Capital, Inc. (“Aeon”) for a Block Trade transaction. The Company issued a warrant to purchase 1,338,889 shares of common stock based upon the Block Trade transaction pursuant to the Company’s engagement agreement with Aeon dated February 22, 2018 (“Aeon Engagement Agreement”). The Company classified these warrants as equity. The warrants have a term of five years with an exercise price of approximately $0.01 per warrant share. Using the Black-Scholes-Merton option pricing model, the Company determined the aggregate fair value of these warrants to be approximately $9,000. The warrants have a cashless exercise feature.

 

Effective July 15, 2019, the Company issued a Common Stock Purchase Warrant to Aeon for a Block Trade transaction. The Company issued a warrant to purchase 1,944,444 shares of common stock based upon the Block Trade pursuant to the Aeon Engagement Agreement. The Company classified these warrants as equity. The warrants have a term of five years with an exercise price of approximately $0.01 per warrant share. Using the Black-Scholes-Merton option pricing model, the Company determined the aggregate fair value of these warrants to be approximately $12,000. The warrants have a cashless exercise feature.

  

Effective July 10, 2020, the Company issued a Common Stock Purchase Warrant to Aeon for a Block Trade transaction. The Company issued a warrant to purchase 4,100,000 shares of common stock based upon the Block Trade pursuant to the Aeon Engagement Agreement. The Company classified these warrants as equity. The warrants have a term of five years with an exercise price of $0.01 per warrant share. Using the Black-Scholes-Merton option pricing model, the Company determined the aggregate fair value of these warrants to be approximately $29,000. The warrants have a cashless exercise feature.

 

Effective July 18, 2020, the Company issued a Common Stock Purchase Warrant to Aeon for a Block Trade transaction. The Company issued a warrant to purchase 3,500,000 shares of common stock based upon the Block Trade pursuant to the Aeon Engagement Agreement. The Company classified these warrants as equity. The warrants have a term of five years with an exercise price of approximately $0.01 per warrant share. Using the Black-Scholes-Merton option pricing model, the Company determined the aggregate fair value of these warrants to be approximately $18,000. The warrants have a cashless exercise feature.

 

Effective July 19, 2020, the Company issued a Common Stock Purchase Warrant to Aeon for a Block Trade transaction. The Company issued a warrant to purchase 1,333,333 shares of common stock based upon the Block Trade pursuant to the Aeon Engagement Agreement. The Company classified these warrants as equity. The warrants have a term of five years with an exercise price of approximately $0.01 per warrant share. Using the Black-Scholes-Merton option pricing model, the Company determined the aggregate fair value of these warrants to be approximately $7,000. The warrants have a cashless exercise feature.

 

Effective July 27, 2020, the Company issued a Common Stock Purchase Warrant to Aeon for a Block Trade transaction. The Company issued a warrant to purchase 2,500,000 shares of common stock based upon the Block Trade pursuant to the Aeon Engagement Agreement. The Company classified these warrants as equity. The warrants have a term of five years with an exercise price of approximately $0.01 per warrant share. Using the Black-Scholes-Merton option pricing model, the Company determined the aggregate fair value of these warrants to be approximately $13,000. The warrants have a cashless exercise feature.

 

A summary of the Company’s warrant activity and related information for the three months ended July 31, 2020 is shown below:

 

    Warrants     Weighted
Average
Exercise Price
 
Outstanding, April 30, 2020     47,890,155     $ 0.05  
Issued     11,433,333       0.01  
Expired            
Outstanding, July 31, 2020     59,323,488       0.04  
Exercisable, July 31, 2020     59,323,488     $ 0.04  

  

The following table summarizes additional information concerning warrants outstanding and exercisable at July 31, 2020:

 

Exercise Prices   Number of
Warrant Shares
Exercisable at
April 30, 2020
    Weighted
Average
Remaining
Contractual
Life
    Weighted
Average
Exercise Price
 
                   
$0.12     17,000,000       0.44          
$0.065     769,231       1.39          
$0.0575     869,565       1.68          
$0.03     2,500,000       2.32          
$0.026     1,923,077       2.91          
$0.025     2,000,000       1.99          
$0.018     1,388,889       2.83          
$0.011     2,272,727       3.25          
$0.01     9,100,000       4.52          
$0.015     833,333       4.72          
$0.009     3,333,333       3.92          
$0.0075     7,333,333       4.97          
$0.005     10,000,000       4.41          
      59,323,488       2.96     $ 0.04